We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2005 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: September 15, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Taiwan University Hospital
Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation

Soft Tissue Neoplasms

Study Type: Observational
Study Design: Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
Official Title: Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002

Resource links provided by NLM:

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 12
Study Start Date: June 2005
Estimated Study Completion Date: August 2005
Detailed Description:
Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma Protuberans (PDFSP) was even rare. To our knowledge, the largest report constituted of 19 cases (five of them had no follow-up (FU) status) (1). So we proposed this retrospective study based on the cancer registry of our hospital. Twelve cases who were diagnosed as DFSP before age of 18 were identified. But all of them had been lost of FU for at least two years. So we will try to contact these patients and asked them to be back to our clinic for routine surveillance (history taking and physical exam and optional local image/chest xray) and quality of life (QoL) evaluation after pathological review if this clinical study was approved (2)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients diagnosed as DFSP before age of 18 after pathological review according to the cancer registry of our hospital

Exclusion Criteria:

  • age > 18 at diagnosis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00173355

Contact: Chun-Ru Chien, M.D. 886-2-23123456 ext 2643 stwo@ha.mc.ntu.edu.tw
Contact: Rong-Sen Yang, M.D, Ph.D 886-2-23516478 ext 3958 yang@ha.mc.ntu.edu.tw

National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Rong-Sen Yang, MD, PhD    886-23123456 ext 3958    yang@ha.mc.ntu.edu.tw   
Contact: Chun-Ru Chien, M.D.    886-2-23516478 ext 2643    stwo@ha.mc.ntu.edu.tw   
Principal Investigator: Rong-Sen Yang, MD, PhD         
Sponsors and Collaborators
National Taiwan University Hospital
Study Chair: Rong-Sen Yang, M.D., Ph.D. National Taiwan University Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00173355     History of Changes
Other Study ID Numbers: 9461700618
First Submitted: September 12, 2005
First Posted: September 15, 2005
Last Update Posted: December 9, 2005
Last Verified: August 2005

Keywords provided by National Taiwan University Hospital:
pediatric Dermatofibrosarcoma Protuberans

Additional relevant MeSH terms:
Soft Tissue Neoplasms
Neoplasms, Fibrous Tissue
Neoplasms, Connective Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms by Site